LB Pharmaceuticals Inc Common Stock (LBRX) is a publicly traded the market company. As of July 11, 2026, LBRX trades at $33.26 with a market cap of $967.55M and a P/E ratio of -10.40. LBRX moved -2.76% today. Year to date, LBRX is +48.02%; over the trailing twelve months it is flat. Its 52-week range spans $13.36 to $35.35. Analyst consensus is strong buy with an average price target of $48.20. Rallies surfaces LBRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for LBRX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $33.26 |
| Market Cap | $967.55M |
| P/E Ratio | -10.40 |
| EPS | $-3.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $35.35 |
| 52-Week Low | $13.36 |
| Volume | 162.71K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-25.20M |
| Gross Margin | 0.00% |
5 analysts cover LBRX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $48.20.